A recent study led by UCLA investigators has demonstrated that an artificial intelligence (AI) tool, Unfold AI, can significantly enhance treatment outcomes for men with prostate cancer by accurately estimating tumor volume. This precision enables physicians to identify patients who are most likely to benefit from partial gland cryoablation, a minimally invasive procedure targeting localized prostate tumors. The study, published in BJUI Compass, suggests that utilizing AI for precise tumor measurement could reduce treatment failures by over 70%.
Partial gland cryoablation involves freezing and destroying only the cancerous portion of the prostate, preserving the remaining healthy tissue. By employing Unfold AI to measure tumor size more precisely, clinicians can better predict which patients are suitable candidates for this focal therapy, potentially improving cure rates and minimizing unnecessary treatments. This advancement underscores the growing role of AI in personalizing cancer treatment and optimizing patient outcomes. Click for More Details
